maybe they couldn't get it posted as soon as they wanted. Because now it just makes them look ridiculous, or maybe short.
Traders Sell Galena Biopharma (GALE) Amid FDA Warning Letter
2:24 PM ET, 04/10/2015 - StreetInsider
Galena Biopharma (Nasdaq: GALE) is seeing some drastic selling as it moves below a key support level Friday.
Money flow is negative $242,000 for an uptick-to-downtick ratio at 0.8 times, suggesting downward pressure on the stock. Moreover, the 14-day money flow index is at 14.5 percent, which is well below the 20 percent threshold for being oversold.
Good to hear from a real person with some idea instead of the huge wash of bot garbage. And by the way, I agree, and nice to peak above $4.
Do you mean the Yahoo mistake that GALE is Fura Emeralds? Actually Fura ticker is GALEF but I guess that is close enough for yahoo.
The U.S. Food and Drug Administration today approved Zarxio (filgrastim-sndz), the first biosimilar product approved in the United States.
Sentiment: Strong Buy
a few weeks ago. And the volume has been pretty good, with much of the up moves coming on volume. Quite the contrast from a few months ago when volume nearly always pushed the price lower.
I guess we'll see if this holds.
BRAINSTORM CELL THERAPEUTICS INC. just came out with a new prospectus, available here. This is an SEC requirement for firms looking to issue certain types of securities. An excerpt of the prospectus is provided below:
USE OF PROCEEDS
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.